ANNA
MERLO
Investigador/a en el periodo 2012-2017
University of Padua
Padua, ItaliaPublicaciones en colaboración con investigadores/as de University of Padua (21)
2017
-
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
OncoImmunology, Vol. 6, Núm. 4
-
Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells
Frontiers in Immunology, Vol. 8, Núm. FEB
2016
-
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer
Journal of Controlled Release, Vol. 236, pp. 79-89
-
Reverse immunoediting: When immunity is edited by antigen
Immunology Letters, Vol. 175, pp. 16-20
2015
-
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer
Oncoscience, Vol. 2, Núm. 4, pp. 373-381
2014
-
Functional avidity-driven activation-induced cell death shapes CTL immunodominance
Journal of Immunology, Vol. 193, Núm. 9, pp. 4704-4711
-
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
PLoS ONE, Vol. 9, Núm. 10
-
Peritoneal tumor carcinomatosis: Pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs
PLoS ONE, Vol. 9, Núm. 11
2013
2012
-
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for epstein-barr-virus-driven disorders
Clinical and Developmental Immunology, Vol. 2012
-
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas
Clinical Cancer Research, Vol. 18, Núm. 15, pp. 4080-4091
-
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma
Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837
2011
-
Differential down-modulation of HLA class i and II molecule expression on human tumor cell lines upon in vivo transfer
Cancer Immunology, Immunotherapy, Vol. 60, Núm. 11, pp. 1639-1645
-
Immunotherapy for EBV-associated malignancies
International Journal of Hematology, Vol. 93, Núm. 3, pp. 281-293
2010
-
Impact of γ-chain cytokines on EBV-specific T cell cultures
Journal of Translational Medicine, Vol. 8
-
Role of CD4 cytotoxic T lymphocytes in the control of viral diseases and cancer
International Reviews of Immunology, Vol. 29, Núm. 4, pp. 371-402
-
The interplay between Epstein-Barr virus and the immune system: A rationale for adoptive cell therapy of EBV-related disorders
Haematologica, Vol. 95, Núm. 10, pp. 1769-1777
-
Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors
Journal of Immunology, Vol. 184, Núm. 10, pp. 5895-5902
2009
-
Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-α or IL-4
European Journal of Immunology, Vol. 39, Núm. 1, pp. 56-66
-
Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors
Cancer Research, Vol. 69, Núm. 24, pp. 9385-9394